News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Open Monoclonal Technology, Inc. Provides Important Intellectual Property Update


4/22/2014 9:37:04 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PALO ALTO, Calif.--(BUSINESS WIRE)--Open Monoclonal Technology, Inc. (OMT) today announced issuance of U.S. patent application 8,703,485 related to inactivation of rodent immunoglobulin genes and generation of human antibodies. The issuance came with a patent term extension of 1,228 days and will further strengthen the intellectual property of the company’s OmniAb™ suite of human therapeutic antibody platforms, including OmniRat®, OmniMouse® and OmniFlic™.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES